Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
41 Factors affecting timing of hypothyroidism following radioactive iodine therapy (RAIT) for patients with Graves' disease: A 12-month observational study Department of Radiotherapy and Nuclear medicine ِAya AbdelBaset Ahmed 2024
42 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2024
43 Prognostic significance of CD3+ and CD8+ T-cells immunoscore in renal cell carcinoma: A comparison between two simple models for assessment Department of Pathology Dr. Shimaa Hassan Shabaan Hassan 2024
44 High Dose Methotrexate Induced Toxicity in Children with Hematological Malignancy: Incidence and Relation to MTX Level Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2024
45 Pediatric cancer mortality: Analyzing early deaths and fatalities in a resource-limited tertiary care context Department of Pediatric Oncology Dr. Amira Mahmoud Mohammed Osman 2024
46 Field and Nodal Irradiation in Early stage Hodgkin’s lymphoma: A single institution study Department of Radiotherapy and Nuclear medicine Dr. Asmaa elsayed abdelsalam /hasaballah 2024
47 TheUseofTraditional and Complementary Medicine by Children with Cancer in Jordan Department of Pediatric Oncology Ahmed Abdelwahab Faraag Mohammed 2024
48 High Dose Methotrexate Induced Toxicity in Children with Hematological Malignancy: Incidence and Relation to MTX Level Department of Pediatric Oncology norhan hassan mahmoud 2024
49 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2024
50 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Department of Medical Oncology Dr. Asmaa Mohamed Zahran Omar 2024